Clinical Care
A more complete approach to cardiovascular risk.
Dr. Marmur brings clinical, academic, research and interventional cardiology experience to a highly individualized approach to cardiovascular risk assessment, prevention and long-term management.
Explore the Assessment Process
↓
Individualized assessment, informed by clinical context.
The Principle
01
No single number tells the whole story.
Cardiovascular assessment may require an understanding of medical and family history, risk factors, biomarkers, imaging, genomic and proteomic information, and established cardiovascular risk models.
The value lies not simply in collecting more data, but in understanding how the information fits together.
Integrated Assessment
Multiple perspectives. One cardiovascular strategy.
Clinical Context
01
Biomarkers
02
Advanced Imaging
03
Genomics
04
Proteomics
05
06
Integrated Interpretation
07
Personalized Management Strategy
01
Foundation
Comprehensive Clinical Evaluation
Thoughtful cardiovascular assessment begins with understanding the individual before selecting testing. The aim is to clarify the questions that matter and determine which information can be most useful.
01
Medical History
02
Family History
03
Previous Testing
04
Current Symptoms
05
Risk Factors
06
Medications
07
Lifestyle Context
Clinical context comes first.
02
Structure & Vascular Health
Advanced cardiovascular imaging
Imaging can provide structural and vascular information within a broader assessment strategy. Its value depends on clinical context and careful interpretation—not simply on the technology itself.
Appropriate testing is considered individually; not every patient requires every modality.
03
Biological Signals
Looking beyond conventional risk factors.
Biological information can add depth to a cardiovascular assessment when it is considered in the context of the individual’s overall risk profile.
01
Metabolic Health
+
02
Inflammatory Context
+
03
Lipid-Related Risk
+
04
Hematologic Factors
+
05
Additional Cardiovascular Biomarkers
+
04
Genomic Risk
Understanding inherited cardiovascular risk.
Genomic information may provide an additional layer of risk context where clinically appropriate. It is one component of a broader, evidence-based cardiovascular strategy.
05
Proteomic Information
Adding another dimension to biological risk assessment.
Proteomic information is another potential input that may help deepen a sophisticated cardiovascular assessment when interpreted alongside clinical findings.
Integration
The individual findings matter.
The relationship between them matters more.
Clinical Context
Imaging
Biomarkers
Genomics
Proteomics
→
Clinical Interpretation
↓
Individual Cardiovascular Risk Profile
↓
Management Priorities
From Assessment to Action
Turning information into a clear cardiovascular strategy.
01
Risk Prioritization
Clarifying which factors deserve the greatest attention.
02
Prevention Strategy
Developing an individualized prevention approach.
03
Treatment Considerations
Considering relevant clinical options in context.
04
Long-Term Follow-Up
Establishing a thoughtful path for ongoing care.
Academic Foundation
Clinical judgment informed by decades of academic cardiology.
Dr. Marmur’s approach is informed by sustained academic leadership, interventional cardiology experience, clinical research, teaching, publications and professional standards work.
01
Chair of Cardiology
NYC Health + Hospitals / Elmhurst
02
Director of Interventional Cardiology
SUNY Downstate · 2003–2026
03
Chief of Cardiology
SUNY Downstate · 2016–2021
04
Professional Standards
ABIM Interventional Cardiology Committee
The Experience
Sophisticated medicine should still feel personal.
01
Initial Conversation
02
Individualized Assessment
03
Integrated Review
04
Management Strategy
05
Ongoing Care
Private Cardiovascular Consultation
Begin with a more complete understanding of cardiovascular risk.
For consultation inquiries and private cardiovascular care in New York City.
Contact the Practice
→
New York City
© 2026 Jonathan D. Marmur, MD. All rights reserved.
Privacy
Accessibility
Terms
Clinical Care
A more complete approach to cardiovascular risk.
Dr. Marmur brings clinical, academic, research and interventional cardiology experience to a highly individualized approach to cardiovascular risk assessment, prevention and long-term management.
Explore the Assessment Process
↓
Individualized assessment, informed by clinical context.
The Principle
01
No single number tells the whole story.
Cardiovascular assessment may require an understanding of medical and family history, risk factors, biomarkers, imaging, genomic and proteomic information, and established cardiovascular risk models.
The value lies not simply in collecting more data, but in understanding how the information fits together.
Integrated Assessment
Multiple perspectives. One cardiovascular strategy.
Clinical Context
01
Biomarkers
02
Advanced Imaging
03
Genomics
04
Proteomics
05
Integrated
Interpretation
06
Personalized Management Strategy
07
01
Foundation
Comprehensive Clinical Evaluation
Thoughtful cardiovascular assessment begins with understanding the individual before selecting testing. The aim is to clarify the questions that matter and determine which information can be most useful.
01
Medical History
02
Family History
03
Previous Testing
04
Current Symptoms
05
Risk Factors
06
Medications
07
Lifestyle Context
Clinical context comes first.
02
Structure & Vascular Health
Advanced cardiovascular imaging
Imaging can provide structural and vascular information within a broader assessment strategy. Its value depends on clinical context and careful interpretation—not simply on the technology itself.
Appropriate testing is considered individually; not every patient requires every modality.
03
Biological Signals
Looking beyond conventional risk factors.
Biological information can add depth to a cardiovascular assessment when it is considered in the context of the individual’s overall risk profile.
01
Metabolic Health
+
02
Inflammatory Context
+
03
Lipid-Related Risk
+
04
Hematologic Factors
+
05
Additional Cardiovascular Biomarkers
+
04
Genomic Risk
Understanding inherited cardiovascular risk.
Genomic information may provide an additional layer of risk context where clinically appropriate. It is one component of a broader, evidence-based cardiovascular strategy.
05
Proteomic Information
Adding another dimension to biological risk assessment.
Proteomic information is another potential input that may help deepen a sophisticated cardiovascular assessment when interpreted alongside clinical findings.
Integration
The individual findings matter.
The relationship between them matters more.
Clinical Context
Imaging
Biomarkers
Genomics
Proteomics
→
Clinical Interpretation
↓
Individual Cardiovascular Risk Profile
↓
Management Priorities
From Assessment to Action
Turning information into a clear cardiovascular strategy.
01
Risk Prioritization
Clarifying which factors deserve the greatest attention.
02
Prevention Strategy
Developing an individualized prevention approach.
03
Treatment Considerations
Considering relevant clinical options in context.
04
Long-Term Follow-Up
Establishing a thoughtful path for ongoing care.
Academic Foundation
Clinical judgment informed by decades of academic cardiology.
Dr. Marmur’s approach is informed by sustained academic leadership, interventional cardiology experience, clinical research, teaching, publications and professional standards work.
Explore Research & Publications
→
About Dr. Marmur
→
01
Chair of Cardiology
NYC Health + Hospitals / Elmhurst
02
Director of Interventional Cardiology
SUNY Downstate · 2003–2026
03
Chief of Cardiology
SUNY Downstate · 2016–2021
04
Professional Standards
ABIM Interventional Cardiology Committee
The Experience
Sophisticated medicine should still feel personal.
01
Initial Conversation
02
Individualized Assessment
03
Integrated Review
04
Management Strategy
05
Ongoing Care
Private Cardiovascular Consultation
Begin with a more complete understanding of cardiovascular risk.
For consultation inquiries and private cardiovascular care in New York City.
Contact the Practice
→
New York City
Author
Controlling the Agenda
Amazon ↗
Audible ↗
© 2026 Jonathan D. Marmur, MD. All rights reserved.
Privacy
Accessibility
Terms
Clinical Care
A more complete approach to cardiovascular risk.
Dr. Marmur brings clinical, academic, research and interventional cardiology experience to a highly individualized approach to cardiovascular risk assessment, prevention and long-term management.
Individualized assessment, informed by clinical context.
The Principle
01
No single number tells the whole story.
Cardiovascular assessment may require an understanding of medical and family history, risk factors, biomarkers, imaging, genomic and proteomic information, and established cardiovascular risk models.
"The value lies not simply in collecting more data, but in understanding how the information fits together."
Integrated Assessment
Multiple perspectives. One cardiovascular strategy.
01
Clinical Context
02
Biomarkers
03
Advanced Imaging
04
Genomics
05
Proteomics
06
Integrated Interpretation
07
Personalized Management Strategy
Foundation
01
Comprehensive Clinical Evaluation
Thoughtful cardiovascular assessment begins with understanding the individual before selecting testing. The aim is to clarify the questions that matter and determine which information can be most useful.
01
Medical History
02
Family History
03
Previous Testing
04
Current Symptoms
05
Risk Factors
06
Medications
07
Lifestyle Context
Clinical context comes first.
Structure & Vascular Health
02
Advanced cardiovascular imaging
Imaging can provide structural and vascular information within a broader assessment strategy. Its value depends on clinical context and careful interpretation—not simply on the technology itself.
Appropriate testing is considered individually; not every patient requires every modality.
Biological Signals
03
Looking beyond conventional risk factors.
Biological information can add depth to a cardiovascular assessment when it is considered in the context of the individual’s overall risk profile.
01
Metabolic Health
+
02
Inflammatory Context
+
03
Lipid-Related Risk
+
04
Hematologic Factors
+
05
Additional Cardiovascular Biomarkers
+
Genomic Risk
04
Understanding inherited cardiovascular risk.
Genomic information may provide an additional layer of risk context where clinically appropriate. It is one component of a broader, evidence-based cardiovascular strategy.
Proteomic Information
05
Adding another dimension to biological risk assessment.
Proteomic information is another potential input that may help deepen a sophisticated cardiovascular assessment when interpreted alongside clinical findings.
Integration
The individual findings matter. The relationship between them matters more.
Patient Inputs
•
Clinical Context
•
Imaging
•
Biomarkers
•
Genomics
•
Proteomics
↓
Clinical Interpretation
↓
Individual Cardiovascular Risk Profile
↓
Management Priorities
From Assessment to Action
Turning information into a clear cardiovascular strategy.
01
Risk Prioritization
Clarifying which factors deserve the greatest attention.
02
Prevention Strategy
Developing an individualized prevention approach.
03
Treatment Considerations
Considering relevant clinical options in context.
04
Long-Term Follow-Up
Establishing a thoughtful path for ongoing care.
Academic Foundation
Clinical judgment informed by decades of academic cardiology.
Dr. Marmur’s approach is informed by sustained academic leadership, interventional cardiology experience, clinical research, teaching, publications and professional standards work.
01
Chair of Cardiology
NYC Health + Hospitals / Elmhurst
02
Director of Interventional Cardiology
SUNY Downstate · 2003–2026
03
Chief of Cardiology
SUNY Downstate · 2016–2021
04
Professional Standards
ABIM Interventional Cardiology Committee
The Experience
Sophisticated medicine should still feel personal.
01
Initial Conversation
02
Individualized Assessment
03
Integrated Review
04
Management Strategy
05
Ongoing Care
Private Cardiovascular Consultation
Begin with a more complete understanding of cardiovascular risk.
For consultation inquiries and private cardiovascular care in New York City.
New York City
Author
Controlling the Agenda
Amazon ↗
Audible ↗
© 2026 Jonathan D. Marmur, MD. All rights reserved.
Privacy
Accessibility
Terms